Insider Transactions in Q3 2021 at Angiodynamics Inc (ANGO)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2021
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,231
-1.72%
|
$33,237
$27.29 P/Share
|
|
Aug 12
2021
|
Stephen A Trowbridge EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,231
+4.32%
|
-
|
|
Aug 12
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
702
-2.42%
|
$18,954
$27.29 P/Share
|
|
Aug 12
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Exercise of conversion of derivative security
|
Direct |
2,395
+7.62%
|
-
|
|
Aug 12
2021
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,021
-2.38%
|
$243,567
$27.29 P/Share
|
|
Aug 12
2021
|
James C Clemmer President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,387
+4.87%
|
-
|
|
Aug 12
2021
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
788
-3.22%
|
$21,276
$27.29 P/Share
|
|
Aug 12
2021
|
Dave Helsel SVP Global Operations and R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
2,685
+9.87%
|
-
|
|
Jul 28
2021
|
Wesley Johnson |
SELL
Payment of exercise price or tax liability
|
Direct |
3,171
-3.55%
|
$82,446
$26.43 P/Share
|
|
Jul 28
2021
|
Wesley Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
5,726
+6.02%
|
$80,164
$14.64 P/Share
|
|
Jul 28
2021
|
Dennis S Meteny |
SELL
Payment of exercise price or tax liability
|
Direct |
3,171
-2.69%
|
$82,446
$26.43 P/Share
|
|
Jul 28
2021
|
Dennis S Meteny |
BUY
Exercise of conversion of derivative security
|
Direct |
5,726
+4.63%
|
$80,164
$14.64 P/Share
|
|
Jul 26
2021
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,105
-0.58%
|
$54,730
$26.1 P/Share
|
|
Jul 26
2021
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
353
-0.51%
|
$9,178
$26.1 P/Share
|
|
Jul 26
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
318
-1.18%
|
$8,268
$26.1 P/Share
|
|
Jul 26
2021
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
419
-0.9%
|
$10,894
$26.1 P/Share
|
|
Jul 21
2021
|
Laura Piccinini SVP International |
BUY
Grant, award, or other acquisition
|
Direct |
2,952
+50.0%
|
-
|
|
Jul 21
2021
|
Richard C Rosenzweig SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
3,098
+18.02%
|
-
|
|
Jul 21
2021
|
Michael E Tarnoff |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+21.41%
|
-
|
|
Jul 21
2021
|
Karen A Licitra |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+16.95%
|
-
|
|
Jul 21
2021
|
Dennis S Meteny |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+4.87%
|
-
|
|
Jul 21
2021
|
Howard W Donnelly |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+5.49%
|
-
|
|
Jul 21
2021
|
Eileen O'Shea Auen |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+11.92%
|
-
|
|
Jul 21
2021
|
Jan Stern Reed |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+11.84%
|
-
|
|
Jul 21
2021
|
Wesley Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+6.42%
|
-
|
|
Jul 21
2021
|
James C Clemmer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
26,189
+6.76%
|
-
|
|
Jul 21
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Grant, award, or other acquisition
|
Direct |
4,388
+13.99%
|
-
|
|
Jul 21
2021
|
Scott Centea SVP/GM, VIT |
BUY
Grant, award, or other acquisition
|
Direct |
2,842
+5.74%
|
-
|
|
Jul 21
2021
|
Dave Helsel SVP Global Operations and R&D |
BUY
Grant, award, or other acquisition
|
Direct |
4,058
+15.68%
|
-
|
|
Jul 21
2021
|
Stephen A Trowbridge EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,408
+9.74%
|
-
|
|
Jul 18
2021
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,483
-0.44%
|
$35,592
$24.76 P/Share
|
|
Jul 18
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
300
-1.31%
|
$7,200
$24.76 P/Share
|
|
Jul 18
2021
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
344
-0.78%
|
$8,256
$24.76 P/Share
|
|
Jul 18
2021
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
417
-2.29%
|
$10,008
$24.76 P/Share
|
|
Jul 18
2021
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
400
-0.65%
|
$9,600
$24.76 P/Share
|
|
Jul 17
2021
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,131
-0.63%
|
$51,144
$24.76 P/Share
|
|
Jul 17
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
262
-1.13%
|
$6,288
$24.76 P/Share
|
|
Jul 17
2021
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
339
-0.76%
|
$8,136
$24.76 P/Share
|
|
Jul 17
2021
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
294
-1.59%
|
$7,056
$24.76 P/Share
|
|
Jul 17
2021
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
354
-0.57%
|
$8,496
$24.76 P/Share
|
|
Jul 14
2021
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,622
-1.35%
|
$120,172
$26.43 P/Share
|
|
Jul 14
2021
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
571
-2.41%
|
$14,846
$26.43 P/Share
|
|
Jul 14
2021
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
500
-1.11%
|
$13,000
$26.43 P/Share
|
|
Jul 14
2021
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
640
-3.35%
|
$16,640
$26.43 P/Share
|
|
Jul 14
2021
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,284
-2.03%
|
$33,384
$26.43 P/Share
|